Postprandial Changes in Solubilizing Capacity of Human Intestinal Fluids for BCS Class II Drugs

By Clarysse Sarah   Psachoulias Dimitrios   Brouwers Joachim   Tack Jan   Annaert Pieter   Duchateau Guus   Reppas Christos   Augustijns Patrick  

Pharmaceutical Research, Vol. 26, Iss. 6, 2009-06 ,pp. : 1456-1466

Springer Publishing Company

Access to resources Recommend Favorite

Assessment of Formulation Factors on the Release Behaviour of BCS Class II Drug from Tablet Dosage form Using DoE

By  

Current Drug Delivery, Vol. 11, Iss. 4, 2014-06 ,pp. : 511-520

Bentham Science Publishers

Access to resources Recommend Favorite

Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System

By Wu Chi-Yuan   Benet Leslie Z.  

Pharmaceutical Research, Vol. 22, Iss. 1, 2005-01 ,pp. : 11-23

Springer Publishing Company

Access to resources Recommend Favorite

Insight into the Development of Dissolution Media for BCS Class II Drugs: A Review from Quality Control and Prediction of In Vivo Performance Perspectives

By  

Current Drug Delivery, Vol. 13, Iss. 7, 2016-10 ,pp. : 1004-1020

Bentham Science Publishers

Access to resources Recommend Favorite

Use of Amino Acids as Counterions Improves the Solubility of the BCS II Model Drug, Indomethacin

By  

Current Drug Delivery, Vol. 8, Iss. 4, 2011-01 ,pp. : 363-372

Bentham Science Publishers

Access to resources Recommend Favorite